Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,037,646
in 4 filings

Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-31 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −1,333 1,334
2024-01-31 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −3,333 6,667
2024-01-31 Schoenberg Mark Chief Medical Officer Grant or award · Restricted Stock Units +10,000 10,000
2024-01-31 Kim Dong Chief Financial Officer Option exercise +3,333 26,585
2024-01-31 Kim Dong Chief Financial Officer Option exercise · Restricted Stock Units −3,333 6,667
2024-01-31 Kim Dong Chief Financial Officer Grant or award · Restricted Stock Units +12,000 12,000
2024-01-31 Barrett Elizabeth A. Chief Executive Officer Grant or award · Restricted Stock Units +87,615 87,615
2023-09-07 Belldegrun Arie Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2023-09-07 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2023-09-07 Cohen Fred E Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2023-09-07 Wildman Daniel George Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2023-09-07 Holden Stuart Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2023-09-07 Robinson James A. Jr. Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2023-09-07 WEN LEANA Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2023-09-07 Smith Jason Drew General Counsel Grant or award · Restricted Stock Units +10,000 10,000
2023-09-07 Kim Dong Chief Financial Officer Grant or award · Restricted Stock Units +7,500 7,500
2023-09-07 Schoenberg Mark Chief Medical Officer Grant or award · Restricted Stock Units +5,000 5,000
2023-08-31 Smith Jason Drew General Counsel Option exercise +8,334 22,207
2023-08-31 Smith Jason Drew General Counsel Sale −3,800 $18.01 $68K 18,407
2023-08-31 Smith Jason Drew General Counsel Option exercise · Restricted Stock Units −8,334 0

Page 9 of 13 · 244 trades